Dan Cowell

Dan Cowell is an experienced biotech executive currently serving as the Chief Operating Officer at Momentous Therapeutics Ltd.12 Here are some key details about his background and career:

Professional Experience

Dan Cowell has over 25 years of experience in the biotech industry, with a proven track record of managing and co-founding innovative companies.2 His career highlights include:

• Chief Operating Officer at Momentous Therapeutics Ltd (2022-present)13
• CEO of Psyomics Ltd (2015-2020)1
• Chief Operating Officer at Horizon Discovery (2010-2014)1
• Co-founder and CEO of Hypoxium (2008-2010)1
• Co-founder and Director of Pharmorphix (2003-2007)1

Education and Expertise

Dan Cowell holds a Bachelor of Science degree in Chemistry from the University of Kent.1 His areas of expertise include:

• Drug discovery and development
• Biotechnology
• Cell biology
• Oncology
• Genomics
• Research and development

Board Positions

In addition to his executive roles, Dan has served on several boards:

• Non-Executive Director at Sentinel Oncology since 20112
• Non-Executive Director at Techspert.io (2016-2020)1
• Non-Executive Director at Euprotec Ltd (2010-2014)1

Entrepreneurial Background

Dan Cowell has a strong entrepreneurial background, having:

• Co-founded and managed multiple biotech companies
• Taken three research services companies from foundation to exit
• Led a gene editing company from start-up to IPO as COO
• Co-founded and managed a digital mental health diagnostics platform2

Current Role at Momentous Therapeutics

As the Chief Operating Officer at Momentous Therapeutics Ltd, Dan Cowell is part of the leadership team driving the company's mission in biotechnology research and development.34 His extensive experience in drug discovery and company management makes him well-suited for this role in an innovative therapeutics company.